These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 20485256

  • 1. Surveillance strategies in inflammatory bowel disease.
    Schmidt C, Bielecki C, Felber J, Stallmach A.
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [Abstract] [Full Text] [Related]

  • 2. Malignant transformation in inflammatory bowel disease - surveillance guide.
    Stallmach A, Bielecki C, Schmidt C.
    Dig Dis; 2009 Jun; 27(4):584-90. PubMed ID: 19897979
    [Abstract] [Full Text] [Related]

  • 3. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA, Polyak S.
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [Abstract] [Full Text] [Related]

  • 4. Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy.
    Hlavaty T, Huorka M, Koller T, Zita P, Kresanova E, Rychly B, Toth J.
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):680-9. PubMed ID: 21602687
    [Abstract] [Full Text] [Related]

  • 5. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L, Miheller P, Tulassay Z.
    Dig Dis; 2007 Aug; 25(3):267-9. PubMed ID: 17827953
    [Abstract] [Full Text] [Related]

  • 6. Reduction of colorectal cancer risk in patients with Crohn's disease.
    Lichtenstein GR.
    Rev Gastroenterol Disord; 2002 Aug; 2 Suppl 2():S16-24. PubMed ID: 12478240
    [Abstract] [Full Text] [Related]

  • 7. Dysplasia and cancer in inflammatory bowel disease.
    Basseri RJ, Basseri B, Papadakis KA.
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
    [Abstract] [Full Text] [Related]

  • 8. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM.
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [Abstract] [Full Text] [Related]

  • 9. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, Fidder HH, Siersema PD, Dekker E, Oldenburg B.
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [Abstract] [Full Text] [Related]

  • 10. Chronic inflammatory bowel disease and cancer.
    Pohl C, Hombach A, Kruis W.
    Hepatogastroenterology; 2000 Jul; 47(31):57-70. PubMed ID: 10690586
    [Abstract] [Full Text] [Related]

  • 11. Inflammatory bowel disease cancer risk, detection and surveillance.
    Rogler G.
    Dig Dis; 2012 Jul; 30 Suppl 2():48-54. PubMed ID: 23207932
    [Abstract] [Full Text] [Related]

  • 12. Surveillance for cancer and dysplasia in inflammatory bowel disease.
    Rubin DT, Kavitt RT.
    Gastroenterol Clin North Am; 2006 Sep; 35(3):581-604. PubMed ID: 16952742
    [Abstract] [Full Text] [Related]

  • 13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Sep; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 14. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.
    Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A.
    Gut; 2004 Dec; 53(12):1813-6. PubMed ID: 15542520
    [Abstract] [Full Text] [Related]

  • 15. Chemoprevention for colon cancer: new opportunities, fact or fiction?
    Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ.
    Scand J Gastroenterol Suppl; 2006 Dec; (243):158-64. PubMed ID: 16782636
    [Abstract] [Full Text] [Related]

  • 16. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort.
    Vienne A, Simon T, Cosnes J, Baudry C, Bouhnik Y, Soulé JC, Chaussade S, Marteau P, Jian R, Delchier JC, Coffin B, Admane H, Carrat F, Drouet E, Beaugerie L.
    Aliment Pharmacol Ther; 2011 Jul; 34(2):188-95. PubMed ID: 21615760
    [Abstract] [Full Text] [Related]

  • 17. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
    Vleggaar FP, Lutgens MW, Claessen MM.
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
    [Abstract] [Full Text] [Related]

  • 18. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
    de Jong DJ, Nagengast FM.
    Ned Tijdschr Geneeskd; 2007 Dec 15; 151(50):2758-60. PubMed ID: 18232192
    [Abstract] [Full Text] [Related]

  • 19. [Surveillance of patients with inflammatory bowel diseases].
    Moshkowitz M, Kariv R, Half B, Vilkin A, Levi Z, Niv Y, Dotan I, Section of Gastrointestinal Oncology of the Israeli Gastroenterological Association.
    Harefuah; 2011 Apr 15; 150(4):389-91, 417. PubMed ID: 22164923
    [Abstract] [Full Text] [Related]

  • 20. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB.
    Gastrointest Endosc; 2007 Jun 15; 65(7):998-1004. PubMed ID: 17451704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.